NFKB1 and autism: Interestingly, our results showed that rPGRN supplemention significantly reduced autism‐like behavior, such as stereotyped behavior and social impairment (Figure 1), and downregulated the NF‐κB pathway, inhibiting microglial activation in the hippocampus of VPA‐induced ASD rats (Figures 2 and 3), aligning with Fu et al.'s findings.40